Bionano Genomics, Inc.
BNGO
$1.14
-$0.03-2.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.40M | -38.59M | -74.33M | -83.70M | -112.02M |
| Total Depreciation and Amortization | 9.73M | 9.79M | 13.05M | 13.65M | 14.23M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -195.00K | 7.85M | 30.74M | 25.61M | 24.71M |
| Change in Net Operating Assets | 514.00K | 2.28M | 4.48M | 880.00K | 4.16M |
| Cash from Operations | -16.35M | -18.67M | -26.06M | -43.56M | -68.92M |
| Capital Expenditure | -- | 0.00 | 0.00 | -77.00K | -103.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.75M | -13.76M | -14.47M | 12.26M | 73.94M |
| Cash from Investing | -12.75M | -13.76M | -14.47M | 12.19M | 73.84M |
| Total Debt Issued | -- | 0.00 | 0.00 | 18.00M | 18.00M |
| Total Debt Repaid | -4.95M | -6.94M | -6.62M | -30.90M | -66.06M |
| Issuance of Common Stock | 31.11M | 36.08M | 33.25M | 42.33M | 44.45M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.12M | -2.81M | -4.36M | -10.61M | -10.08M |
| Cash from Financing | 24.04M | 26.33M | 22.27M | 18.82M | -13.69M |
| Foreign Exchange rate Adjustments | -11.00K | -22.00K | -13.00K | 10.00K | -7.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.06M | -6.13M | -18.27M | -12.53M | -8.78M |